Insider: Zoghbi Huda Y Director - REGENERON PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,703 | 0 | 1,703 |
| Value | $1,297,430.55 | $0.00 | $1,297,430.55 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/19/2026 | DDS | 4 | Direct | COM | $790.00 | $3,160.00 | 1,703 |
| 02/19/2026 | DDS | 53 | Direct | COM | $778.47 | $41,258.91 | 3,189 |
| 02/19/2026 | DDS | 50 | Direct | COM | $775.50 | $38,775.00 | 3,242 |
| 02/19/2026 | DDS | 49 | Direct | COM | $774.68 | $37,959.32 | 3,292 |
| 02/19/2026 | DDS | 331 | Direct | COM | $780.45 | $258,328.95 | 2,650 |
| 02/19/2026 | DDS | 208 | Direct | COM | $779.55 | $162,146.40 | 2,981 |
| 02/19/2026 | DDS | 209 | Direct | COM | $781.28 | $163,287.52 | 2,441 |
| 02/19/2026 | DDS | 160 | Direct | COM | $784.45 | $125,512.00 | 1,763 |
| 02/19/2026 | DDS | 56 | Direct | COM | $785.61 | $43,994.16 | 1,707 |
| 02/19/2026 | DDS | 298 | Direct | COM | $782.10 | $233,065.80 | 2,143 |
| 02/19/2026 | DDS | 220 | Direct | COM | $783.29 | $172,323.80 | 1,923 |
| 10/13/2023 | DDS | 1,000 | Direct | COM | $850.00 | $850,000.00 | 1,247 |
| 03/16/2022 | DDS | 2,000 | Direct | COM | $675.00 | $1,350,000.00 | 1,082 |
| 09/14/2021 | DDS | 998 | Direct | COM | $650.00 | $648,700.00 | 891 |
| 09/13/2021 | DDS | 2 | Direct | COM | $651.10 | $1,302.20 | 891 |
| 07/07/2020 | DDS | 1,706 | Direct | COM | $650.00 | $1,108,900.00 | 643 |
| 06/11/2020 | DDS | 1,706 | Direct | COM | $625.00 | $1,066,250.00 | 643 |
| 06/10/2020 | DDS | 330 | Direct | COM | $608.62 | $200,844.60 | 1,619 |
| 06/10/2020 | DDS | 251 | Direct | COM | $607.64 | $152,517.64 | 1,949 |
| 06/10/2020 | DDS | 149 | Direct | COM | $606.64 | $90,389.36 | 2,200 |
| 06/10/2020 | DDS | 202 | Direct | COM | $610.41 | $123,302.82 | 1,256 |
| 06/10/2020 | DDS | 161 | Direct | COM | $609.48 | $98,126.28 | 1,458 |
| 06/10/2020 | DDS | 164 | Direct | COM | $611.46 | $100,279.44 | 1,092 |
| 06/10/2020 | DDS | 80 | Direct | COM | $615.28 | $49,222.40 | 742 |
| 06/10/2020 | DDS | 99 | Direct | COM | $616.19 | $61,002.81 | 643 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research